Page last updated: 2024-08-17

nad and Dementia, Vascular

nad has been researched along with Dementia, Vascular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Guan, X; Jiang, G; Pang, T; Tang, L; Xie, L; Zhao, N; Zhu, X1
Haushofer, M; Jellinger, KA; Kraxberger, E; Mucke, HA; Rainer, M1

Trials

1 trial(s) available for nad and Dementia, Vascular

ArticleYear
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
    Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:12

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Drug Therapy, Combination; Female; Humans; Language; Male; Memory; Mental Status Schedule; Middle Aged; NAD; Orientation; Psychiatric Status Rating Scales; Psychological Tests; Treatment Failure

2000

Other Studies

1 other study(ies) available for nad and Dementia, Vascular

ArticleYear
The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
    Cellular and molecular neurobiology, 2023, Volume: 43, Issue:8

    Topics: Animals; Cognitive Dysfunction; Cytidine Diphosphate Choline; Dementia, Vascular; NAD; Neuroinflammatory Diseases; Neuronal Outgrowth; Nicotinamide Mononucleotide; Rats; Sirtuin 1

2023